XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Redeemable Common Stock, Stock Options, Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Redeemable Common Stock
Notes Receivable for Redeemable Common Stock Issued
Redeemable Stock Options
Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Notes Receivable for Common Stock Issued
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Temporary Equity, Beginning Balance, Amount at Dec. 31, 2020   $ 80,780 $ 803 $ 53,085 $ 353,300          
Temporary Equity, Beginning Balance, Shares at Dec. 31, 2020   3,813,450     14,376,272          
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2020 $ (430,591)               $ (3) $ (430,588)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2020           1        
Exercise of stock options   $ 6,922   (5,715)            
Exercise of stock options, shares   280,545                
Stock-based compensation expense 1,239           $ 1,239      
Unrealized gain on short-term investments and cash equivalents, net of tax 7               7  
Foreign currency translation adjustment (4)               (4)  
Change in notes receivable for common stock issued     (14)              
Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock 86,885 $ (87,702) 817     $ 4 87,698 $ (817)    
Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock, shares   (4,093,995)       4,093,995        
Reclassification of redeemable common stock options to common stock options 47,370     (47,370)     47,370      
Net loss (6,805)                 (6,805)
Temporary Equity, Ending Balance, Amount at Mar. 31, 2021         $ 353,300          
Temporary Equity, Ending Balance, Shares at Mar. 31, 2021         14,376,272          
Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2021 (301,899)         $ 4 136,307 (817)   (437,393)
Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2021           4,093,996        
Temporary Equity, Beginning Balance, Amount at Dec. 31, 2020   $ 80,780 $ 803 $ 53,085 $ 353,300          
Temporary Equity, Beginning Balance, Shares at Dec. 31, 2020   3,813,450     14,376,272          
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2020 (430,591)               (3) (430,588)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2020           1        
Unrealized gain on short-term investments and cash equivalents, net of tax 3                  
Net loss (20,282)                  
Temporary Equity, Ending Balance, Amount at Jun. 30, 2021         $ 353,300          
Temporary Equity, Ending Balance, Shares at Jun. 30, 2021         14,376,272          
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2021 (313,396)         $ 4 137,838 (365) (3) (450,870)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2021           4,124,211        
Temporary Equity, Beginning Balance, Amount at Mar. 31, 2021         $ 353,300          
Temporary Equity, Beginning Balance, Shares at Mar. 31, 2021         14,376,272          
Stockholders' Equity, Beginning Balance, Amount at Mar. 31, 2021 (301,899)         $ 4 136,307 (817)   (437,393)
Stockholders' Equity, Beginning Balance, Shares at Mar. 31, 2021           4,093,996        
Exercise of stock options 125           125      
Exercise of stock options, shares           30,215        
Stock-based compensation expense 1,406           1,406      
Unrealized gain on short-term investments and cash equivalents, net of tax (4)               (4)  
Foreign currency translation adjustment 1               1  
Change in notes receivable for common stock issued 452             452    
Net loss (13,477)                 (13,477)
Temporary Equity, Ending Balance, Amount at Jun. 30, 2021         $ 353,300          
Temporary Equity, Ending Balance, Shares at Jun. 30, 2021         14,376,272          
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2021 (313,396)         $ 4 137,838 $ (365) (3) (450,870)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2021           4,124,211        
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2021 $ 138,242         $ 27 617,511   (20) (479,276)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2021 27,366,746         27,366,746        
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares           145,922        
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount $ 308           308      
Shares redeemed for employee tax withholdings           (26,983)        
Value of shares redeemed for employee tax withholdings (362)           (362)      
Stock-based compensation expense 2,649           2,649      
Unrealized gain on short-term investments and cash equivalents, net of tax (74)               (74)  
Foreign currency translation adjustment (4)               (4)  
Net loss (17,596)                 (17,596)
Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2022 123,163         $ 27 620,106   (98) (496,872)
Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2022           27,485,685        
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2021 $ 138,242         $ 27 617,511   (20) (479,276)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2021 27,366,746         27,366,746        
Conversion of preferred stock to common stock upon initial public offering, net of fractional shares settled (in shares) 4,093,995                  
Unrealized gain on short-term investments and cash equivalents, net of tax $ (150)                  
Net loss (34,328)                  
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2022 $ 109,986         $ 27 623,746   (183) (513,604)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2022 27,631,479         27,631,479        
Stockholders' Equity, Beginning Balance, Amount at Mar. 31, 2022 $ 123,163         $ 27 620,106   (98) (496,872)
Stockholders' Equity, Beginning Balance, Shares at Mar. 31, 2022           27,485,685        
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares           99,743        
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount 277           277      
Stock-based compensation expense 2,904           2,904      
Unrealized gain on short-term investments and cash equivalents, net of tax (76)               (76)  
Foreign currency translation adjustment (9)               (9)  
Shares issued for the employee stock purchase plan, shares           46,051        
Shares issued for the employee stock purchase plan 459           459      
Net loss (16,732)                 (16,732)
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2022 $ 109,986         $ 27 $ 623,746   $ (183) $ (513,604)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2022 27,631,479         27,631,479